Condensed Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 44,424	$ 20,323
Prepaid expenses and other current assets	2,112	2,326
Total current assets	46,536	22,649
Property and equipment, net	916	681
Operating right-of-use asset, net	230	284
Restricted cash	100	100
Deferred offering costs	332	332
Total assets	48,114	24,046
Current liabilities:
Accounts payable	3,310	2,400
Accrued expenses and other current liabilities	3,306	4,931
Deferred revenue, current	18,215
Total current liabilities	24,831	7,331
Deferred revenue, non-current	9,421
Other long-term liabilities		62
Total liabilities	34,252	7,393
Commitments and contingencies (Note 7)
Stockholders' equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued or outstanding at March 31, 2023 and December 31, 2022, respectively
Common stock, $0.0001 par value; 200,000,000 shares authorized; 12,194,184 and 12,128,843 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively	1	1
Additional paid-in capital	134,132	132,653
Accumulated deficit	(120,271)	(116,001)
Total stockholders' equity	13,862	16,653
Total liabilities and stockholders' equity	$ 48,114	$ 24,046